Compositions and methods for treating anemia

Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemi...

Full description

Saved in:
Bibliographic Details
Main Authors ETTE, ENE IKPONG, MARONI, BRADLEY JOHN, CHANDORKAR, GURUDATT AJAY, HARTMAN, CHARLOTTE SUZANNE, FARZANEH-FAR, RAMIN, SMITH, ALEXANDER, INRIG, JULIA KERN
Format Patent
LanguageChinese
English
Published 01.11.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.
Bibliography:Application Number: TW202110101093